ArticlePloS one2020

Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.

Xavier Armoiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.